Summary: John Carreyrou's Bad Blood: Secret and Lies in a Silicon Valley Startup

Readers of John Carreyrou's Bad Blood: Secret and Lies in a Silicon Valley Startup seeking engagement for all reading groups can gain further insight with this essential resource as a guide to aid your discussions.

John Carreyrou’s national bestselling book Bad Blood: Secrets and Lies in a Silicon Valley Startup received positive reviews from critics. The New York Times Book Review says that Bad Blood is chilling and is like “a West Coast version of All the President’s Men."

Prize-winning journalist Carreyrou reveals the full inside story regarding the rise and fall of the multibillion-dollar biotech startup Theranos. He was the first to break the story and he pursued it until the end in the midst of pressure from the CEO and threats from her lawyers. In 2014, the CEO and founder of Theranos Elizabeth Holmes was labeled the female Steve Jobs. She was backed by multi-billion dollars worth of investment. There as just one problem: The technology failed to work.

Bad Blood: Secrets and Lies in a Silicon Valley Startup is a riveting story of one of the biggest corporate frauds since Enron. This is a story of ambition, lies, and hubris set in Silicon Valley.

In this comprehensive look into John Carreyrou's Bad Blood: Secret and Lies in a Silicon Valley Startup, you'll be equipped to prepare with the following:

Discussion aid which includes a wealth of prompts and information

Overall plot synopsis and author biography

Thought-provoking discussion questions for a deeper examination

Creative exercises to foster alternate “if this was you” discussions

And much more!

Note to readers: This is a companion guide based on John Carreyrou's Bad Blood: Secret and Lies in a Silicon Valley Startup This is meant to enhance and aid your reading experience, not to replace it. We strongly encourage you to purchase the original book before purchasing this unofficial companion guide.

© 2018 HSP (E-Book): 6610000120291

Erscheinungsdatum

E-Book: 22. Oktober 2018